ROCHESTER, N.Y. — Bausch + Lomb on Friday appointed a clinical professor of ophthalmology to serve as the company's first-ever chief medical officer.
As CMO, Calvin Roberts will coordinate B + L's research and development efforts across its vision care, pharmaceuticals and surgical business units.
In addition to his role at Bausch + Lomb, Roberts is a clinical professor of ophthalmology at Weill Medical College of Cornell University. He also is a member of the board of directors at Alimera Sciences, a biopharmaceutical company he co-founded in 2003.
“I look forward to bringing the perspective of clinical optometrists and ophthalmologists to the development of new, innovative products to benefit our patients,” Roberts said. “Bausch + Lomb has a history of great science and great scientists, and working together we can best serve the needs of our customers and patients.”